ABOS
Acumen Pharmaceuticals, Inc.
NASDAQ · USHealthcareBiotechnology
$2.21-1.78%
Price as of Jul 20, 2026
ABOS capital
Acumen Pharmaceuticals, Inc. capital & dividend
Leverage, liquidity, debt coverage and shareholder-distribution metrics.
Leverage
- Debt / equity
- 0.36x
- Net debt / equity
- -0.24x
- Debt / assets
- 0.23x
- Debt / EBITDA
- -0.29x
- Net debt / EBITDA
- 0.19x
Liquidity & coverage
- Current ratio
- 4.55x
- Quick ratio
- 4.55x
- Cash ratio
- 4.39x
- Interest coverage
- -26.84x
- EBITDA / interest
- -25.49x
- Working capital
- $103.9M
Cash & dividend
- FCF / debt
- -3.39x
- Cash flow / debt
- -3.39x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.